Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00667173 · ClinicalTrials.gov registry record · Phase 2
A Clinical Study Evaluating the Safety and Efficacy of IDP-115 in Patients With Rosacea
A Phase 2 study, sponsored by Dow Pharmaceutical Sciences.
- Completed
- Registry status
- Phase 2
- Development phase
- 140
- Enrollment target
NCT00667173 is a Phase 2 study that has completed, run by Dow Pharmaceutical Sciences. The registered enrollment target is 140 participants.
The verdict
NCT00667173, a Phase 2 study, has completed, sponsored by Dow Pharmaceutical Sciences.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 140 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the safety and effectiveness of IDP-115 in treating patients with rosacea.
Interventions
- DRUG Vehicle
- DRUG IDP-115
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2007-11 |
| Est. Completion | 2008-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00667173
The ClinicalTrials.gov registry entry for NCT00667173 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dow Pharmaceutical Sciences, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vehicle is the first listed.
NCT00667173 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00667173 about?
NCT00667173 is a clinical study titled "A Clinical Study Evaluating the Safety and Efficacy of IDP-115 in Patients With Rosacea". The purpose of this study is to assess the safety and effectiveness of IDP-115 in treating patients with rosacea.
What is the current status of trial NCT00667173?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 140 participants. The study started on 2007-11. Estimated completion is 2008-07.
What interventions are being tested in trial NCT00667173?
The interventions under investigation include: Vehicle (DRUG), IDP-115 (DRUG).
Who is sponsoring clinical trial NCT00667173?
This trial is sponsored by Dow Pharmaceutical Sciences, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.